Your browser doesn't support javascript.
loading
Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms.
Soldath, Patrick; Binderup, Tina; Kjaer, Andreas; Knigge, Ulrich; Langer, Seppo W; Petersen, René H.
Afiliação
  • Soldath P; European Neuroendocrine Tumor Society Center of Excellence, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Binderup T; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Kjaer A; Department of Cardiothoracic Surgery, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Knigge U; European Neuroendocrine Tumor Society Center of Excellence, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Langer SW; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Copenhagen University Hospital-Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
  • Petersen RH; European Neuroendocrine Tumor Society Center of Excellence, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Eur J Cardiothorac Surg ; 65(2)2024 Feb 01.
Article em En | MEDLINE | ID: mdl-38305412
ABSTRACT

OBJECTIVES:

The mean standardized uptake value (SUVmean) and maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose-positron emission tomography are prognostic biomarkers for survival and nodal involvement in non-small-cell lung cancer but their prognostic value in lung neuroendocrine neoplasms (NENs) remains unexplored. In this study, we aimed to examine whether they are also prognostic biomarkers for survival and nodal involvement in lung NENs.

METHODS:

We retrospectively studied patients with typical carcinoid, atypical carcinoid or large cell neuroendocrine carcinoma who had been radically resected at our institution between 2008 and 2020. We measured SUVmean and SUVmax on all primary tumours and lymph nodes that were clinically and/or pathologically involved. We dichotomized the patients into groups of high or low SUVmean and SUVmax of the primary tumour using time-dependent receiver operating characteristic curves and compared their overall survival using Kaplan-Meier curves and Cox models. Lastly, we predicted the patients' pathological nodal status with SUVmean and SUVmax of the lymph nodes using binomial logistic models.

RESULTS:

The study included 245 patients. Patients died earlier if their SUVmean of the primary tumour exceeded 3.9 [hazard ratio 1.97, 95% confidence interval (CI) 1.27-3.04, P = 0.002] or SUVmax exceeded 5.3 (hazard ratio 1.85, 95% CI 1.20-2.87, P = 0.006). Likewise, patients had a higher risk of pathological nodal involvement if their SUVmean of the lymph nodes exceeded 3.3 (odds ratio 10.00, 95% CI 2.59-51.01, P = 0.002) or SUVmax exceeded 4.2 (odds ratio 4.00, 95% CI 1.20-14.65, P = 0.028).

CONCLUSIONS:

The fluorine-18 fluorodeoxyglucose-positron emission tomography SUVmean and SUVmax are strong prognostic biomarkers for survival and nodal involvement in lung NENs and could be important guides for making treatment decisions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos de Flúor / Tumor Carcinoide / Carcinoma Neuroendócrino / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cardiothorac Surg Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos de Flúor / Tumor Carcinoide / Carcinoma Neuroendócrino / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Cardiothorac Surg Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca